Pasithea Therapeutics Corp. (KTTAW) Net Shares Issued and Repurchased (2021 - 2025)

Pasithea Therapeutics has disclosed Net Shares Issued and Repurchased across 5 years of filings, most recently posting $1.5 million for Q4 2025.

• In Q4 2025, Net Shares Issued and Repurchased rose 1369.39% year-over-year to $1.5 million; the TTM figure through Dec 2025 stood at $1.5 million (up 1369.39% YoY), while the FY2025 annual figure was $1.5 million, up 1369.39% from the prior year.
• Net Shares Issued and Repurchased came in at $1.5 million for Q4 2025 at Pasithea Therapeutics, up from $4478.0 in the prior quarter.
• In the past five years, Net Shares Issued and Repurchased ranged from a high of $1.5 million in Q4 2025 to a low of $4478.0 in Q3 2025.
• Average Net Shares Issued and Repurchased over 5 years is $338165.4, with a median of $43383.5 recorded in 2023.
• Year-over-year, Net Shares Issued and Repurchased slumped 95.14% in 2024 and jumped 1369.39% in 2025.
• Over 5 years, Net Shares Issued and Repurchased stood at $600000.0 in 2021, then surged by 33.33% to $800000.0 in 2022, then plunged by 94.5% to $44000.0 in 2023, then surged by 137.35% to $104433.0 in 2024, then jumped by 1369.39% to $1.5 million in 2025.
• Per Business Quant data, the three most recent Net Shares Issued and Repurchased figures were $1.5 million in Q4 2025, $4478.0 in Q3 2025, and $13528.0 in Q2 2025.